SS
Steve Seedhouse Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
27
Avg Return
Past Year
Past Year
24%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
71.4%
Neutral
28.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $35 |
76%
upside
| 1 | -5.1% |
0
%
| 13 Jan ‘26 6 days ago |
|
|
|
Overweight
Maintained
| $34 |
149%
upside
| 1 | +72% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Overweight
Assumed
| $154 |
1%
downside
| 1 | +29% |
0
%
| 24 Nov ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | +44% |
0
%
| 13 Nov ‘25 2 months ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | +59% |
0
%
| 12 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $42 |
228%
upside
| 1 | +5.5% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $31 |
59%
upside
| 1 | +1.1% |
0
%
| 6 Nov ‘25 2 months ago |
|